These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Carrier screening in the community. Brock DJ J Inherit Metab Dis; 1995; 18(4):525-32. PubMed ID: 7494411 [TBL] [Abstract][Full Text] [Related]
24. Counting the benefits of screening: a pilot study of willingness to pay for cystic fibrosis carrier screening. Miedzybrodzka Z; Shackley P; Donaldson C; Abdalla M J Med Screen; 1994 Apr; 1(2):82-3. PubMed ID: 8790491 [No Abstract] [Full Text] [Related]
25. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis. Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275 [TBL] [Abstract][Full Text] [Related]
26. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis. Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936 [TBL] [Abstract][Full Text] [Related]
28. [Orientation on genetic screening for cystic fibrosis]. Brandt NJ; Schwartz M; Skovby F Ugeskr Laeger; 1991 May; 153(19):1365-8. PubMed ID: 2042248 [No Abstract] [Full Text] [Related]
29. Proceed with much more caution. Schmidtke J Hum Genet; 1994 Jul; 94(1):25-7; discussion 28-30. PubMed ID: 8034291 [No Abstract] [Full Text] [Related]
30. Carrier screening for cystic fibrosis. Beaudet AL Am J Hum Genet; 1990 Oct; 47(4):603-5. PubMed ID: 2220802 [No Abstract] [Full Text] [Related]
31. Factors influencing health insurers' decisions to cover new genetic technologies. Schoonmaker MM; Bernhardt BA; Holtzman NA Int J Technol Assess Health Care; 2000; 16(1):178-89. PubMed ID: 10815363 [TBL] [Abstract][Full Text] [Related]
32. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Haddow JE; Bradley LA; Palomaki GE; Doherty RA J Med Screen; 1999; 6(2):60-6. PubMed ID: 10444721 [TBL] [Abstract][Full Text] [Related]
35. Association between carrier screening and incidence of cystic fibrosis. Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057 [TBL] [Abstract][Full Text] [Related]
36. The ethics of cystic fibrosis carrier screening: where do we stand? De Braekeleer M; Mélançon MJ Am J Hum Genet; 1990 Sep; 47(3):580-1. PubMed ID: 2393029 [No Abstract] [Full Text] [Related]
37. Screening for cystic fibrosis carriers. Schulman JD; Maddalena A; Black SH; Bick DP Am J Hum Genet; 1990 Oct; 47(4):740. PubMed ID: 2220812 [No Abstract] [Full Text] [Related]
38. Statement of the American Society of Human Genetics on cystic fibrosis carrier screening. Am J Hum Genet; 1992 Dec; 51(6):1443-4. PubMed ID: 1463021 [No Abstract] [Full Text] [Related]
39. An update on cystic fibrosis screening. Goetzinger KR; Cahill AG Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569 [TBL] [Abstract][Full Text] [Related]
40. Socioeconomic status and uptake of reproductive carrier screening in Australia. Robson SJ; Caramins M; Saad M; Suthers G Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):976-979. PubMed ID: 32748403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]